TECHNOLOGY SUMMARY

A shelf-stable, off-the-shelf skin substitute engineered with preserved blood vessel structures and antimicrobial nanoparticles. DEVA helps chronic and burn wounds heal faster by integrating better with patient tissue, reducing infection risk, and eliminating the need for cold storage.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech & Medical

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

Vetted Programs/Awards: 1. NY I-Corps (2024) and NSF I-Corps (2025) 2. Awarded funding from The Mathers Foundation ($646K) and SUNY Technology Accelerator Fund (TAF) ($50K) (both 2025) 3. Venture Champions Competition Winner (2024)

SHOWCASE SUMMARY

Organization Type: Startup Technology Company

Website: https://vascuarch.com/

MARKET KEYWORDS

Market Keywords: Advanced wound care, Burn & trauma treatment, Regenerative medicine